Sunday's trade in Tel Aviv has opened with a rise in the the leading indexes, but turnover remains thin at NIS 24 million. The Maof-25 index of blue chips has risen by 1.51% to 471.83 points and the TA-100 index has climbed 1.48% to 457.75 points.
(Nasdaq:TEVA) has jumped 8.5% on a turnover of NIS 10 million, the session's highest so far. The shares opened on a positive arbitrage gap of 8.2%. The hike is being attributed to Teva's February 8 announcement that it had won FDA approval to market two generic drugs, one for high blood pressure and the other an anti-inflammatory.
(Nasdaq:NICE) has fallen 3.8% on a NIS 3.7 million turnover, having opened on a negative arbitrage gap of 6.9%. Last Thursday, Nice plunged 15% after releasing a profit warning for its fourth quarter of 2000 and correcting its annual financial results. Nice also announced the dismissal of 220 workers, 100 of which will be fired from its development center in Israel.